Home    Back

93. Primary biliary cholangitis
230 clinical trials,   215 drugs   (DrugBank: 51 drugs),   34 drug target genes,   107 drug target pathways

Searched query = "Primary biliary cholangitis", "Primary biliary cirrhosis", "PBC"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1ChiCTR2000032053
2020-05-012020-04-19Application value of ultrasonography combined with transient elastography for staging of hepatic fibrosis in patients with primary biliary cholangitis (PBC)Application value of ultrasonography combined with transient elastography for staging of hepatic fibrosis in patients with primary biliary cholangitis (PBC) primary biliary cholangitisGold Standard:Any two of the following items met:
1. increased biochemical indicators of cholestasis such as alkaline phosphatase;
2. positive serum AMA or AMA-M2;
3. hepatic histopathology.;Index test:high-frequency and low-frequency ultrasound?transient elastography (TE);		You'an Hospital, Capital Medical UniversityNULLPending1870BothTarget condition:100;Difficult condition:270N/AChina
2ChiCTR1900024836
2019-07-302019-07-30Exploration of non-invasive diagnostic model of liver fibrosis based on artificial intelligence in primary biliary cholangitis Clinical research protocolExploration of non-invasive diagnostic model of liver fibrosis based on artificial intelligence in primary biliary cholangitis Clinical research protocol Primary biliary cholangitisGold Standard:Liver biopsy pathology.;Index test:Non-invasive diagnostic model for liver fibrosis: including AST/PLT value index (APRI model), Forns model, S index, and based on this, a new non-invasive liver fibrosis diagnosis model is generated.;Beijing You'an Hospital, Capital Medical UniversityNULLRecruiting1880BothTarget condition:180;Difficult condition:180China